Does FDA Guidance About Pharma Communications with Payors Open a Path to Off-Label Discussions?
admin
January 18, 2017
At the November, 2016, FDA public hearing on off-label promotion, representatives of the drug industry made a case for allowing companies to...
Does FDA Guidance About Pharma Communications with Payors Open a Path to Off-Label Discussions?
Reviewed by admin
on
January 18, 2017
Rating:
Reviewed by admin
on
January 18, 2017
Rating:
